RecallHawk

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PS...

PHARM ASSOC

Summary

FDA approved BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE) by PHARM ASSOC. ANDA (Generic) approval (Labeling) on 2023-05-08. SYRUP, ORAL.

Details

Source

Drug Approval

External ID

ANDA202940-4

Action Date

2023-05-08

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (generic: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE), SYRUP, ORAL. Application: ANDA202940

Context & Analysis

PHARM ASSOC has 13 FDA actions in our database.

Frequently Asked Questions

How often does PHARM ASSOC have FDA actions?

PHARM ASSOC has 13 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA202940-4" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions